These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Successful alternate day guanidine therapy following guanidine-induced neutropenia in the Lambert-Eaton myasthenic syndrome. Silbert PL; Hankey GJ; Barr AL Muscle Nerve; 1990 Apr; 13(4):360-1. PubMed ID: 2355949 [No Abstract] [Full Text] [Related]
4. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis. Brown JC; Johns RJ Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895 [No Abstract] [Full Text] [Related]
5. [Editorial: The pathophysiology of myasthenia gravis and the myasthenic syndrome]. Rotshenker S; Rahamimoff R Harefuah; 1972 Oct; 83(8):344-5. PubMed ID: 4669730 [No Abstract] [Full Text] [Related]
6. Treatment of myasthenia. II. Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956 [No Abstract] [Full Text] [Related]
7. [Lambert-Eaton syndrome. A contribution to its pathogenesis, diagnosis and therapy]. Schütte J; Niederle N; Seeber S Med Welt; 1983 Jan; 34(1):19-22. PubMed ID: 6298559 [No Abstract] [Full Text] [Related]
8. Guanidine therapy in myasthenic syndrome. Koga M; Sato Y; Tateishi J; Ishimoto S; Doi H; Kuroiwa Y Folia Psychiatr Neurol Jpn; 1979; 33(1):65-9. PubMed ID: 222656 [No Abstract] [Full Text] [Related]
19. Myasthenic diseases and related physiology. Howard FM Arch Phys Med Rehabil; 1966 Mar; 47(3):137-46. PubMed ID: 5904918 [No Abstract] [Full Text] [Related]